Home / News / FAQ
FAQ

FAQ on Xtant Medical's Partnership with B2i Digital to Educate Investors on Orthobiologics Innovation

FaqStaq News - Just the FAQs July 28, 2025
By FAQstaq Staff
Read Original Article →
FAQ on Xtant Medical's Partnership with B2i Digital to Educate Investors on Orthobiologics Innovation

Summary

Xtant Medical partners with B2i Digital to provide investor-focused content on its orthobiologics platform, aiming to highlight its market opportunity and long-term value proposition.

What is the purpose of the partnership between Xtant Medical and B2i Digital?

The partnership aims to deliver centralized, investor-focused content to help retail and institutional audiences gain insight into Xtant’s orthobiologics platform and its long-term value proposition.

Why is this partnership significant for Xtant Medical?

This collaboration is significant as it helps Xtant Medical share its growth story and the value of its comprehensive biologics platform with the investment community, enhancing connections with current and prospective shareholders.

How does Xtant Medical’s vertically integrated model benefit its strategy?

Xtant Medical’s vertically integrated model allows it to offer a full-service product line, underpinning its strategy for driving margin improvement and long-term, sustainable growth through a robust R&D pipeline.

Who is involved in this partnership?

The partnership involves Xtant Medical Holdings, a global medical technology company, and B2i Digital, Inc., a firm that partners with public companies to connect them with investors.

What are the key products of Xtant Medical?

Xtant Medical’s key products include bone-healing grafts, growth-factor biologics, cellular allografts, synthetics, and amnion products for orthopedic and neurosurgical specialists.

How has Xtant Medical performed financially recently?

Xtant Medical reported fiscal year 2024 revenue of $117.5 million, a 29% year-over-year increase, demonstrating strong business fundamentals.

What market access has Xtant Medical established?

Xtant Medical has established significant market access through 450 integrated delivery network (IDN) contracts and a network of over 670 independent distributors, serving a $2.5 billion U.S. orthobiologics market.

Who can be contacted for more information about B2i Digital?

For more information about B2i Digital, David Shapiro, Chief Executive Officer, can be contacted via email at [email protected] or through their website https://b2idigital.com.

QR Code for Content Provenance

This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire

Article Control ID: 123732